Mizuho Maintains Buy on Immunocore Hldgs, Raises Price Target to $86
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Graig Suvannavejh has maintained a Buy rating on Immunocore Holdings (IMCR) and increased the price target from $72 to $86. This adjustment reflects a positive outlook on the company's future performance.
February 16, 2024 | 11:52 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho has reaffirmed its Buy rating on Immunocore Holdings and raised the price target from $72 to $86, indicating a strong positive outlook on the company.
The increase in price target by a reputable analyst such as Graig Suvannavejh from Mizuho signals a strong vote of confidence in Immunocore Holdings' future performance and potential for growth. This is likely to positively influence investor sentiment and could lead to an uptick in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100